SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-19-014455
Filing Date
2019-03-18
Accepted
2019-03-18 07:20:17
Documents
46
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A tv515433_10qa.htm 10-Q/A 347333
2 EXHIBIT 31.1 tv515433_ex31-1.htm EX-31.1 9697
3 EXHIBIT 31.2 tv515433_ex31-2.htm EX-31.2 9707
4 EXHIBIT 32.1 tv515433_ex32-1.htm EX-32.1 4123
5 EXHIBIT 32.2 tv515433_ex32-2.htm EX-32.2 4157
  Complete submission text file 0001144204-19-014455.txt   3063204

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plx-20180930.xml EX-101.INS 729161
7 XBRL TAXONOMY EXTENSION SCHEMA plx-20180930.xsd EX-101.SCH 27766
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20180930_cal.xml EX-101.CAL 30494
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20180930_def.xml EX-101.DEF 167076
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20180930_lab.xml EX-101.LAB 192401
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20180930_pre.xml EX-101.PRE 194022
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33357 | Film No.: 19686803
SIC: 2836 Biological Products, (No Diagnostic Substances)